Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05B
- Chemical subgroupN05BE
- Chemical substanceN05BE01Buspirone
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 4 medicines
CBG-MEB · 3 medicines
PHARMAC · 2 medicines
MS · 2 medicines · Historical list
SFDA · 2 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
49 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Buspirone | Canada | 5 MG | Tablet | Authorised | Apotex INC |
| Buspirone | Canada | 10 MG | Tablet | Authorised | Apotex INC |
| Buspirone | Canada | 10 MG | Tablet | Cancelled | Sanis Health INC |
| Buspirone Hydrochloride | United States | 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 12.5MG … | tablet | Marketed | Aurobindo Pharma LTD |
| Buspirone Tablets | Canada | 10 MG | Tablet | Marketed | Sanis Health INC |
| Buspirone Viatris | New Zealand | Tab 5 mg | Funded | ||
| Buspirone Viatris | New Zealand | Tab 10 mg | Funded | ||
| Buspirone Hydrochloride Tablets, USP | Canada | 10 MG | Tablet | Authorised | Strides Pharma Canada INC |
| Amb-Buspirone | Canada | 10 MG | Tablet | Marketed | Ambicare Pharmaceuticals INC. |
| PMS-Buspirone | Canada | 10 MG | Tablet | Marketed | Pharmascience INC |
| Pro-Buspirone | Canada | 10 MG | Tablet | Marketed | Pro Doc Limitee |
| Auro-Buspirone | Canada | 10 MG | Tablet | Marketed | Auro Pharma INC |
| Jamp Buspirone | Canada | 10 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Mint-Buspirone | Canada | 10 MG | Tablet | Marketed | Mint Pharmaceuticals INC |
| Teva-Buspirone | Canada | 10 MG | Tablet | Marketed | Teva Canada Limited |
| Pro-Buspirone | Canada | 5 MG | Tablet | Authorised | Pro Doc Limitee |
| Apo-Buspirone | Canada | 10 MG | Tablet | Not marketed | Apotex INC |
| Bucapsol | United States | 10MG, 15MG, 5MG … | capsule | Marketed | Epic Pharma LLC |
| Buspar | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Bristol Myers Squibb |
| Buspar | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | capsule | Not marketed | Bristol Myers Squibb |
| Co Buspirone | Canada | 10 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Dom-Buspirone | Canada | 10 MG | Tablet | Cancelled | Dominion Pharmacal |
| FTP-Buspirone | Canada | 10 MG / TAB | Tablet | Cancelled | FTP-Pharmacal INC. |
| PMS-Buspirone | Canada | 5 MG | Tablet | Cancelled | Pharmascience INC |
| Mylan-Buspirone | Canada | 10 MG | Tablet | Cancelled | Mylan Pharmaceuticals Ulc |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of Anvisa, CBG-MEB, FDA, Health Canada, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.